Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103396429B reveals enzymatic synthesis of silicon chiral centers. Achieve >99% ee with mild conditions. Reliable supplier for cost reduction in fine chemical manufacturing.
Patent CN104711313A details enzymatic resolution for eldecalcitol intermediates. This method ensures high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel enzymatic route for posaconazole intermediate improves yield and purity. Cost-effective manufacturing solution for antifungal API supply chains.
Patent CN108192932B details a mild enzymatic route for chiral alcohols, offering high ee values and scalable production for pharmaceutical intermediates.
Discover the enzymatic synthesis route for Nilaparib intermediates described in CN111072550A. Achieve high purity and cost efficiency in API manufacturing with our advanced catalytic technologies.
Advanced lipase CALB mutant technology enables high-purity pharmaceutical intermediates manufacturing with reduced costs and enhanced supply chain reliability for global buyers.
Patent CN116024282B details enzymatic dynamic kinetic resolution for high purity S nornicotine offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111778229B reveals high-efficiency hydrolase mutants for >99% ee production. Ideal for reliable pharma intermediate supply chains.
Novel enzymatic dynamic kinetic resolution for high-purity (R)-praziquantel. Reduces cost and improves supply chain reliability for API manufacturing.
Novel CvFAP mutant enables high-purity L-glufosinate synthesis via blue light catalysis, offering significant cost and supply chain advantages for herbicide manufacturers.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN100463903C reveals a novel hydrolase method for producing high-purity (S)-indoline-2-carboxylic acid, offering significant cost reduction in API manufacturing.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN102994470A details a novel Aus EH-B enzyme for high-purity chiral epichlorohydrin. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN109180496B details a novel lipase-catalyzed resolution and Mitsunobu reaction for Cinacalcet. Achieve high purity without hazardous reducing agents.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Discover the environmentally friendly synthesis of chiral 2,3-alkenols using lipase catalysis. A breakthrough in pharmaceutical intermediate manufacturing offering high purity and cost efficiency.
Patent CN1240646C details a novel enzymatic process for high-purity (-)-menthol. Discover cost-effective synthetic routes and supply chain advantages for global procurement.